CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptors.

作者: Morvarid Kabir , Malini S. Iyer , Joyce M. Richey , Orison O. Woolcott , Isaac Asare Bediako

DOI: 10.1152/AJPENDO.00196.2015

关键词:

摘要: The improvement of hepatic insulin sensitivity by the cannabinoid receptor 1 (CB1R) antagonist rimonabant (RIM) has been recently reported to be due upregulation adiponectin. Several studies demonstrated that in clearance accompanies enhancement sensitivity. However, effects RIM on (HIC) have not fully explored. aim this study was explore molecular mechanism(s) which affects HIC, specifically determine whether liver adiponectin receptors (ADRs) and other key genes regulated mediate effects. To induce resistance skeletal muscle liver, dogs were fed a hypercaloric high-fat diet (HFD) for 6 wk. Thereafter, while still maintained HFD, animals received (HFD+RIM; n = 11) or placebo (HFD+PL; 9) an additional 16 calculated as metabolic rate (MCR), estimated from euglycemic-hyperinsulinemic clamp. HFD+PL group showed decrease MCR; contrast, HFD+RIM increased MCR. Consistently, expression involved CEACAM-1 IDE, well gene ADRs, group, but group. We also found positive correlation between insulin-degrading enzyme IDE with ADRs. Interestingly, lipid oxidation conclude fat-fed enhances appears linked pathway.

参考文章(55)
Bandgar T, Menon Ps, Joshi As, Shah Ns, Rathi Pm, Vima Mv, Joshi, Prashanth M, Shah, John M, Thakkar H, Ganesh Hk, Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Journal of Association of Physicians of India. ,vol. 57, pp. 205- 210 ,(2009)
Josef Wanninger, Markus Neumeier, Christa Buechler, Adiponectin, a key adipokine in obesity related liver diseases. World Journal of Gastroenterology. ,vol. 17, pp. 2801- 2811 ,(2011) , 10.3748/WJG.V17.I23.2801
Anders H. Berg, Terry P. Combs, Xueliang Du, Michael Brownlee, Philipp E. Scherer, The adipocyte-secreted protein Acrp30 enhances hepatic insulin action Nature Medicine. ,vol. 7, pp. 947- 953 ,(2001) , 10.1038/90992
Marilyn Ader, Darko Stefanovski, Stella P. Kim, Joyce M. Richey, Viorica Ionut, Karyn J. Catalano, Katrin Hucking, Martin Ellmerer, Gregg Van Citters, Isabel R. Hsu, Jenny D. Chiu, Orison O. Woolcott, Lisa N. Harrison, Dan Zheng, Maya Lottati, Cathryn M. Kolka, Vahe Mooradian, Justin Dittmann, Sophia Yae, Huiwen Liu, Ana Valeria B. Castro, Morvarid Kabir, Richard N. Bergman, Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog. Obesity. ,vol. 22, pp. 1238- 1245 ,(2014) , 10.1002/OBY.20625
Mingyan Zhou, Aimin Xu, Paul KH Tam, Karen SL Lam, Lawrence Chan, Ruby LC Hoo, Jing Liu, Kim HM Chow, Yu Wang, None, Mitochondrial Dysfunction Contributes to the Increased Vulnerabilities of Adiponectin Knockout Mice to Liver Injury Hepatology. ,vol. 48, pp. 1087- 1096 ,(2008) , 10.1002/HEP.22444
Takashi Kadowaki, Toshimasa Yamauchi, Adiponectin and Adiponectin Receptors Endocrine Reviews. ,vol. 26, pp. 439- 451 ,(2005) , 10.1210/ER.2005-0005
Luc F Van Gaal, Aila M Rissanen, André J Scheen, Olivier Ziegler, Stephan Rössner, None, Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study The Lancet. ,vol. 365, pp. 1389- 1397 ,(2005) , 10.1016/S0140-6736(05)66374-X
R Buzzetti, A Petrone, S Zavarella, S Zampetti, M Spoletini, S Potenziani, G Leto, J Osborn, F Leonetti, The glucose clamp reveals an association between adiponectin gene polymorphisms and insulin sensitivity in obese subjects International Journal of Obesity. ,vol. 31, pp. 424- 428 ,(2007) , 10.1038/SJ.IJO.0803419
John T. Heiker, David Kosel, Annette G. Beck-Sickinger, Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors Biological Chemistry. ,vol. 391, pp. 1005- 1018 ,(2010) , 10.1515/BC.2010.104
Magali Gary-Bobo, Ghizlane Elachouri, Jean François Gallas, Philip Janiak, Pietro Marini, Christine Ravinet-Trillou, Michèle Chabbert, Noël Cruccioli, Christian Pfersdorff, Claude Roque, Michèle Arnone, Tiziano Croci, Philippe Soubrié, Florence Oury-Donat, Jean Pierre Maffrand, Bernard Scatton, Frederic Lacheretz, Gérard Le Fur, Jean Marc Herbert, Mohammed Bensaid, Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. Hepatology. ,vol. 46, pp. 122- 129 ,(2007) , 10.1002/HEP.21641